Related Experiment Videos
Lithium carbonate treatment in familial cyclic neutropenia
American Journal of Clinical Pathology
|January 1, 1984
Insights
Cyclic neutropenia, a condition causing low neutrophil counts, was studied in a patient over 58 days. Lithium carbonate treatment did not alter the cycle
Area of Science:
- Hematology
- Pharmacology
Background:
- Cyclic neutropenia is a rare blood disorder characterized by periodic drops in neutrophil counts.
- Understanding treatment efficacy is crucial for managing this condition.
Observation:
- A patient with established cyclic neutropenia was monitored for 48 days without treatment.
- Blood counts were taken every three days, confirming a 21-day cycle of neutropenia.
- Lithium carbonate was initiated on day 49, maintaining therapeutic serum levels.
Findings:
- Lithium carbonate treatment did not impact the periodicity or severity of neutropenic cycles.
- Neutrophil nadirs remained profoundly low despite lithium administration.
Implications:
- This study suggests lithium carbonate may not be an effective treatment for cyclic neutropenia.
- Further research is needed to explore alternative therapeutic strategies for cyclic neutropenia.
Abstract:
A patient with previously documented cyclic neutropenia was followed for 48 days on no treatment. Blood counts obtained at 3-day intervals confirmed the presence of cyclic neutropenia with virtually complete disappearance of neutrophils at the nadir of cycles with a periodicity of 21 days. Lithium carbonate treatment was begun on day 49. Serum lithium levels remained in the therapeutic range throughout the study interval of 58 days. Periodicity and depth of neutropenia were not diminished during the study period.